Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. K. (Karina) Meijer

Publicaties

Accumulating evidence for direct oral anticoagulants in liver disease

Adoption of antithrombotic stewardship and utilization of clinical decision support systems—A questionnaire-based survey in Dutch hospitals

Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH

Antithrombotic Questionnaire Tool for Evaluation of Combined Antithrombotic Therapy in Community Pharmacies

Association of periodontitis with cardiometabolic and haemostatic parameters

Can hemophilia be cured? It depends on the definition

Damoctocog Alfa Pegol, a PEGylated B-domain Deleted Recombinant Extended Half-life Factor VIII for the Treatment of Hemophilia A: A Product Review

Genetic variants, thrombocytopenia, and clinical phenotype of type 2B von Willebrand disease: a median 16-year follow-up study

Interim analyses of the multinational real-world prospective cohort HEM-POWR study evaluating the effectiveness and safety of damoctocog alfa pegol in patients with hemophilia A

Patient-reported data on the severity of Von Willebrand disease

Lees meer

Pers/media

Na je 40e vergroot de anticonceptiepil de kans op trombose

Zorgen over anticonceptiepil na 35ste

Dit wil je weten over de bijwerkingen van bloedverdunners

Gentherapie als wapen tegen hemofilie B

Drie patiënten genezen van hemofilie B na onderzoek in UMCG

Hoop voor hemofilie B patiënten door nieuwe gentherapie

NVHP webinars terugkijken

Kijk terug: webinar gentherapie en webinar Hemofilie in Nederland

Lees meer